135 related articles for article (PubMed ID: 10604413)
1. Cyclin D1 and p53 overexpression predicts multiple primary malignant neoplasms of the hypopharynx and esophagus.
Kohmura T; Hasegawa Y; Ogawa T; Matsuura H; Takahashi M; Yanagita N; Nakashima T
Arch Otolaryngol Head Neck Surg; 1999 Dec; 125(12):1351-4. PubMed ID: 10604413
[TBL] [Abstract][Full Text] [Related]
2. Altered p16/MTS1/CDKN2 and cyclin D1/PRAD-1 gene expression is associated with the prognosis of squamous cell carcinoma of the esophagus.
Takeuchi H; Ozawa S; Ando N; Shih CH; Koyanagi K; Ueda M; Kitajima M
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2229-36. PubMed ID: 9815619
[TBL] [Abstract][Full Text] [Related]
3. [Expression of cell cycle related proteins cyclin D1, p53 and p21WAF1/Cip1 in esophageal squamous cell carcinoma].
Lin DC; Shi ZZ; Xue LY; Chen W; Xu X; Han YL; Lv N; Wang MR
Yi Chuan; 2010 May; 32(5):455-60. PubMed ID: 20466633
[TBL] [Abstract][Full Text] [Related]
4. [The expression of p53, p16, cyclin D1 in esophageal squamous cell carcinoma and esophageal dysplasia].
Kim SG; Hong SJ; Kwon KW; Jung SW; Kim WY; Jung IS; Ko BM; Ryu CB; Kim YS; Moon JH; Kim JO; Cho JY; Lee JS; Lee MS; Shim CS; Kim BS
Korean J Gastroenterol; 2006 Oct; 48(4):269-76. PubMed ID: 17060721
[TBL] [Abstract][Full Text] [Related]
5. Expression of cyclin D1 and p53 and its correlation with proliferative activity in the spectrum of esophageal carcinomas induced after duodenal content reflux and 2,6-dimethylnitrosomorpholine administration in rats.
Pera M; Fernandez PL; Pera M; Palacín A; Cardesa A; Dasenbrock C; Tillman T; Mohr U
Carcinogenesis; 2001 Feb; 22(2):271-7. PubMed ID: 11181448
[TBL] [Abstract][Full Text] [Related]
6. Cyclin D1 expression in oral squamous cell carcinomas: clinicopathological relevance and correlation with p53 expression.
Lam KY; Ng IO; Yuen AP; Kwong DL; Wei W
J Oral Pathol Med; 2000 Apr; 29(4):167-72. PubMed ID: 10766394
[TBL] [Abstract][Full Text] [Related]
7. Mutant p53 and cyclin A1 protein expression in primary laryngeal squamous cell carcinomas do not correlate to second primary tumours of the head and neck.
Farhadieh RD; Smee R; Rees CG; Salardini A; Eggleton S; Yang JL; Russell PJ
ANZ J Surg; 2009; 79(1-2):48-54. PubMed ID: 19183379
[TBL] [Abstract][Full Text] [Related]
8. Evaluating the Correlation Between the Survival Rate of Patients with Esophageal Squamous Cell Carcinoma and Expression of p53 and Cyclin D1 Biomarkers Along with Other Prognostic Factors.
Saemi N; Khoshnevis J; Akbari ME; Meysamie A; Korourian A; Gholizadeh B; Larijani L; Moradi A; Baikpour M; Baikpour M; Zham H
J Gastrointest Cancer; 2018 Mar; 49(1):35-40. PubMed ID: 27975182
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of cyclin D1 indicates a poor prognosis in squamous cell carcinoma of the head and neck.
Michalides RJ; van Veelen NM; Kristel PM; Hart AA; Loftus BM; Hilgers FJ; Balm AJ
Arch Otolaryngol Head Neck Surg; 1997 May; 123(5):497-502. PubMed ID: 9158396
[TBL] [Abstract][Full Text] [Related]
10. Prospective study of cyclin D1 overexpression in Barrett's esophagus: association with increased risk of adenocarcinoma.
Bani-Hani K; Martin IG; Hardie LJ; Mapstone N; Briggs JA; Forman D; Wild CP
J Natl Cancer Inst; 2000 Aug; 92(16):1316-21. PubMed ID: 10944553
[TBL] [Abstract][Full Text] [Related]
11. Alterations of p53, cyclin D1 and pRB expression in the carcinogenesis of esophageal squamous cell carcinoma.
Kawakubo H; Ozawa S; Ando N; Kitagawa Y; Mukai M; Ueda M; Kitajima M
Oncol Rep; 2005 Dec; 14(6):1453-9. PubMed ID: 16273238
[TBL] [Abstract][Full Text] [Related]
12. Cyclin D1 expression predicts postoperative distant metastasis and survival in resectable esophageal squamous cell carcinoma.
Hou X; Liang RB; Wei JC; Xu Y; Fu JH; Luo RZ; He JH; Zhang LJ; Lin P; Yang HX
Oncotarget; 2016 May; 7(21):31088-96. PubMed ID: 27145270
[TBL] [Abstract][Full Text] [Related]
13. Amplification and expression of the cyclin D1 gene in anal and esophageal squamous cell carcinomas.
Sheyn I; Noffsinger AE; Heffelfinger S; Davis B; Miller MA; Fenoglio-Preiser CM
Hum Pathol; 1997 Mar; 28(3):270-6. PubMed ID: 9042789
[TBL] [Abstract][Full Text] [Related]
14. Cyclin D1 overexpression in esophageal cancer from southern China and its clinical significance.
Xiao-Ping H; Tie-Hua R; Peng L; Qiu-Liang W; Guang-Yu Y; Jing-Hui H; Xiao-Dong S; Xiao-Dong L; Bao-Jiang L; Peng-Yuan Z; Kai L; Zhi-Fan H
Cancer Lett; 2006 Jan; 231(1):94-101. PubMed ID: 16051426
[TBL] [Abstract][Full Text] [Related]
15. Cyclin D1 overexpression in primary hypopharyngeal carcinomas.
Masuda M; Hirakawa N; Nakashima T; Kuratomi Y; Komiyama S
Cancer; 1996 Aug; 78(3):390-5. PubMed ID: 8697381
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of cyclins D1 and E is frequent in bronchial preneoplasia and precedes squamous cell carcinoma development.
Lonardo F; Rusch V; Langenfeld J; Dmitrovsky E; Klimstra DS
Cancer Res; 1999 May; 59(10):2470-6. PubMed ID: 10344760
[TBL] [Abstract][Full Text] [Related]
17. p53 and cyclin D1 as prognostic factors in squamous cell carcinoma of the larynx.
Vielba R; Bilbao J; Ispizua A; Zabalza I; Alfaro J; Rezola R; Moreno E; Elorriaga J; Alonso I; Baroja A; de la Hoz C
Laryngoscope; 2003 Jan; 113(1):167-72. PubMed ID: 12514403
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of cyclin D1 occurs in both squamous carcinomas and adenocarcinomas of the esophagus and in adenocarcinomas of the stomach.
Arber N; Gammon MD; Hibshoosh H; Britton JA; Zhang Y; Schonberg JB; Roterdam H; Fabian I; Holt PR; Weinstein IB
Hum Pathol; 1999 Sep; 30(9):1087-92. PubMed ID: 10492044
[TBL] [Abstract][Full Text] [Related]
19. Cyclin D1 overexpression in esophageal dysplasia: a possible biomarker for carcinogenesis of esophageal squamous cell carcinoma.
Shamma A; Doki Y; Shiozaki H; Tsujinaka T; Yamamoto M; Inoue M; Yano M; Monden M
Int J Oncol; 2000 Feb; 16(2):261-6. PubMed ID: 10639568
[TBL] [Abstract][Full Text] [Related]
20. Alterations of rb pathway components are frequent events in patients with oral epithelial dysplasia and predict clinical outcome in patients with squamous cell carcinoma.
Soni S; Kaur J; Kumar A; Chakravarti N; Mathur M; Bahadur S; Shukla NK; Deo SV; Ralhan R
Oncology; 2005; 68(4-6):314-25. PubMed ID: 16020958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
